Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SCLX

Scilex (SCLX)

Scilex Holding Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCLX
DateTimeSourceHeadlineSymbolCompany
03/05/20244:13PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
03/05/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
03/05/20244:01PMGlobeNewswire Inc.Scilex Holding Company Announces Closing of $10 Million Bought Deal OfferingNASDAQ:SCLXScilex Holding Company
03/05/20249:00AMGlobeNewswire Inc.Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the FirNASDAQ:SCLXScilex Holding Company
03/04/20244:02PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SCLXScilex Holding Company
03/04/20249:00AMGlobeNewswire Inc.Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information UpdatesNASDAQ:SCLXScilex Holding Company
03/02/20243:25PMGlobeNewswire Inc.Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento tNASDAQ:SCLXScilex Holding Company
03/01/20246:17AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
03/01/20246:14AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
03/01/20246:11AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
03/01/20246:07AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/29/20245:32PMGlobeNewswire Inc.Scilex Holding Company Announces $10 Million Bought Deal OfferingNASDAQ:SCLXScilex Holding Company
02/29/20245:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
02/29/20245:18PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SCLXScilex Holding Company
02/28/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.NASDAQ:SCLXScilex Holding Company
02/27/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)NASDAQ:SCLXScilex Holding Company
02/27/20246:42AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/27/20246:37AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/27/20246:35AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/27/20246:31AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/27/20246:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
02/26/20244:53PMGlobeNewswire Inc.Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement AgreementNASDAQ:SCLXScilex Holding Company
02/26/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones MetNASDAQ:SCLXScilex Holding Company
02/23/20244:11PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SCLXScilex Holding Company
02/20/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹NASDAQ:SCLXScilex Holding Company
02/20/20246:27AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/20/20246:25AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/20/20246:21AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/20/20246:19AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
02/20/20246:17AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
 Showing the most relevant articles for your search:NASDAQ:SCLX

Your Recent History

Delayed Upgrade Clock